The PERSONAL COVID BP clinical trial run by digital therapeutics company Closed Loop Medicine (CLM), aimed to validate the development of a novel combination product that links a drug to a smart phone app, enabling remote management of patients with hypertension during the COVID-19 pandemic. In this case study we cover: The background and objectives of this research for patients with Hypertension The study’s recruitment objectives How uMed helped CLM exceeds their targets and move the study into its delivery phase

Find out how uMed helped successfully recruit 73% of referred patients into this study within 21 days, not only meeting but far exceeding the study’s recruitment objectives...